Becker's Healthcare December 13, 2023
The FDA and American Academy of Pediatrics have greenlit the weight loss drug Wegovy for adolescents, but pediatricians are still hesitant to prescribe the medication, The New York Times reported Dec. 11.
Many physicians have cited the lack of long-term safety data as a key reason for their reluctance, saying too little is known about the drug’s long-term effects. Edward Lewis, MD, a pediatrician in Rochester, N.Y., told the Times he is disinclined to use “a medicine that is a relative newcomer to the scene in kids.”
Drug shortages and insurance hurdles are also dissuading physicians from prescribing Wegovy, according to the report. Most private insurers require physicians to submit pre-approval forms for the drug, which can be time-consuming, according...
Today's Sponsors
Today's Sponsor